Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
NCT06183359

Self-Identification Program

Led by University Hospital, Montpellier · Updated on 2025-09-30

86

Participants Needed

1

Research Sites

179 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Conduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), compared to a control group receiving an acceptance and commitment therapy (ACT; (1st level of 3rd wave CBT, a well-known psychotherapy). Main judgment criteria : Therapeutic response (reduction ≥ 50% between pre and immediate post-treatment), and rate of relapse at 6 months post-therapy. Secondary objectives: Evaluate psychological processes involved in the reduction of moral pain, diligence, ruminations, suicidal ideas, self-concept and alterations in functioning (mental and social), psychological skills.

CONDITIONS

Official Title

Self-Identification Program

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 to 70 years
  • Presenting a current major depressive episode according to DSM 571
  • Diagnosis may be part of unipolar or bipolar depressive disorder
Not Eligible

You will not qualify if you...

  • Patients with a psychotic disorder
  • Active suicidal thoughts with intention to act (C-SSRS ideation score  4 in the last week)
  • Unable to receive informed information about the study
  • Exclusion period due to participation in a previous study
  • Adults under legal protection such as guardianship or curatorship
  • Not affiliated with or beneficiary of a French social security scheme
  • Unable to give informed written consent
  • Pregnant or breastfeeding women
  • Patients under judicial protection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU Montpellier

Montpellier, France

Actively Recruiting

Loading map...

Research Team

D

Déborah Ducasse, MD

CONTACT

V

Véronique Brand Arpon, IDE

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here